目前，美国海军却在不断将“提康德罗加”级巡洋舰退役， 意味着每退役一艘该型导弹巡洋舰，美国海军的VLS装置就将缩水122单元 （舰上总共有128 ...

About VLS-1488 VLS-1488 is a novel, oral small molecule inhibitor of KIF18A, a kinesin protein essential for cancer cell division and a synthetic lethal target in chromosomally unstable cancers.

Volastra Therapeutics today announced the dosing of the first patient in a Phase I/II clinical trial evaluating VLS-1488.

- Elumina is a Phase 2, multicenter, double-blind, randomized, placebo-controlled, clinical trial to assess the efficacy, safety and tolerability of VLS-01 (buccal film DMT) in people suffering ...

In a bid to improve the Mogami class's anti-submarine warfare (ASW) capabilities, Japan has begun installing the vertical launching system (VLS) on selected hulls of the ...